- Full Year 2023 Medacta Group SA Earnings Call TranscriptMar 13, 2024CHF125.4 (-0.47%)Earnings
- Full Year 2023 Medacta Group SA Corporate Sales Call TranscriptFeb 02, 2024
- Half Year 2023 Medacta Group SA Earnings Call TranscriptSep 22, 2023CHF119.82 (-3.53%)Earnings
- Half Year 2023 Medacta Group SA Corporate Sales Call TranscriptJul 28, 2023
- Full Year 2022 Medacta Group SA Earnings Call TranscriptMar 17, 2023CHF100.92 (-2.19%)Earnings
- Q4 2022 Medacta Group SA Unaudited Top-Line Figures Call TranscriptFeb 03, 2023
- Half Year 2022 Medacta Group SA Earnings Call TranscriptSep 09, 2022CHF88.7 (+2.19%)Earnings
- Half Year 2022 Medacta Group SA Earnings Call TranscriptJul 29, 2022CHF93.92 (+1.64%)Earnings
- Full Year 2021 Medacta Group SA Earnings Call TranscriptMar 11, 2022CHF110.2 (-5.76%)Earnings
- Q4 2021 Medacta Group SA Corporate Sales Call TranscriptJan 20, 2022
- Half Year 2021 Medacta Group SA Earnings Call TranscriptSep 10, 2021Earnings
- Half Year 2021 Medacta Group SA Corporate Sales Call TranscriptJul 20, 2021
- Full Year 2020 Medacta Group SA Earnings Call TranscriptMar 31, 2021Earnings
- Full Year 2020 Medacta Group SA Corporate Sales Call TranscriptJan 21, 2021
- Half Year 2020 Medacta Group SA Earnings Call TranscriptSep 07, 2020Earnings
- Half Year 2020 Medacta Group SA Earnings Call TranscriptJul 22, 2020Earnings
- Full Year 2019 Medacta Group SA Earnings Call TranscriptApr 06, 2020Earnings
Half Year 2022 Medacta Group SA Earnings Call Transcript
First of all, we apologize for the technical problems we have seen today on the platform. We were hoping to be able to host it on time. And I'm glad we managed to recover still today.
So I'm here today with Corrado Farsetta and Gianna La Rana. We can go through the very good and strong results we reported in H1 2022. We can see the highlights of the semester starting with 19% growth in terms of revenues reported, which is 14.6% at constant currency. This growth was driven by a significant new customer acquisition, sales force expansion and new product introduction, especially in the first months of the year in Australia and in the U.S. We still had some headwind coming from the dynamic restrictions and hospital staffing shortages.
We wanted to highlight here as well that Medacta is truly generating significant growth. So compared to prepandemic level, H1 2019, Medacta grew 36.5% at constant currency, which is a CAGR of almost 11%.
A very important milestone, this semester was the achievement of 100 NextAR platforms in the market. We
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)